• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重变化对肥胖儿童血清转氨酶活性的影响。

Effect of weight changes on serum transaminase activities in obese children.

作者信息

Tazawa Y, Noguchi H, Nishinomiya F, Takada G

机构信息

Department of Pediatrics, Akita University School of Medicine, Japan.

出版信息

Acta Paediatr Jpn. 1997 Apr;39(2):210-4. doi: 10.1111/j.1442-200x.1997.tb03583.x.

DOI:10.1111/j.1442-200x.1997.tb03583.x
PMID:9141256
Abstract

To examine the effect of weight changes on serum transaminase activities, glutamic oxaloacetic and pyruvic transaminases (GOT/GPT), a 3-month observation of 110 obese outpatients treated by a mild regimen for obesity was carried out. Patients were divided into two major groups, group I (n = 73) and group II (n = 37), with or without persistent elevation of serum GOT/GPT (> 30 IU/L), and retrospectively classified into four subgroups according to weight changes: group A, weight loss > 5%; group B, weight loss of < 5%; group C, an increase of < 5%; group D, an increase > 5%. In group IA, the incidence of cases with normalization of serum GOT/GPT was 70% and was significantly greater than those of the other three subgroups, respectively (P < 0.01). The incidences of decreased serum GOT/GPT activities were observed corresponding to the degree of weight changes not only in group I (100-27%) but also in group II (100-33%). These facts indicate that a mild regimen for obese outpatients for 3 months, significantly improves serum transaminase activities in patients not only with weight reduction but also weight gain, and that fatty liver may be present even in obese children with normal serum transaminase levels. The normalization of serum GPT activity in patients with weight gain suggests the presence of another factor contributing hypertransaminasemia in pediatric obese patients.

摘要

为研究体重变化对血清转氨酶活性(谷草转氨酶/谷丙转氨酶,GOT/GPT)的影响,对110例接受轻度肥胖治疗方案的肥胖门诊患者进行了为期3个月的观察。患者分为两大组,第一组(n = 73)和第二组(n = 37),根据血清GOT/GPT是否持续升高(> 30 IU/L),并根据体重变化回顾性分为四个亚组:A组,体重减轻> 5%;B组,体重减轻< 5%;C组,体重增加< 5%;D组,体重增加> 5%。在IA组中,血清GOT/GPT恢复正常的病例发生率为70%,显著高于其他三个亚组(P < 0.01)。不仅在第一组(100% - 27%),而且在第二组(100% - 33%)中,均观察到血清GOT/GPT活性降低的发生率与体重变化程度相对应。这些事实表明,对肥胖门诊患者进行3个月的轻度治疗方案,不仅能显著改善体重减轻患者的血清转氨酶活性,也能改善体重增加患者的血清转氨酶活性,并且即使血清转氨酶水平正常的肥胖儿童也可能存在脂肪肝。体重增加患者血清GPT活性恢复正常表明,小儿肥胖患者高转氨酶血症可能存在其他促成因素。

相似文献

1
Effect of weight changes on serum transaminase activities in obese children.体重变化对肥胖儿童血清转氨酶活性的影响。
Acta Paediatr Jpn. 1997 Apr;39(2):210-4. doi: 10.1111/j.1442-200x.1997.tb03583.x.
2
Elevation of glutamic pyruvic transaminase and gamma-glutamyl transpeptidase in obesity.肥胖症患者谷丙转氨酶和γ-谷氨酰转肽酶升高。
Tohoku J Exp Med. 1980 Dec;132(4):473-8. doi: 10.1620/tjem.132.473.
3
Serum glutamic oxaloacetic transaminase (GOT) and glutamic pyruvic transaminase (GPT) levels in diabetes mellitus.糖尿病患者血清谷草转氨酶(GOT)和谷丙转氨酶(GPT)水平
Indian J Med Sci. 1989 May;43(5):118-21.
4
The relationship between serum transaminase activities and fatty liver in children with simple obesity.单纯性肥胖儿童血清转氨酶活性与脂肪肝的关系
Acta Paediatr Jpn. 1995 Oct;37(5):621-5. doi: 10.1111/j.1442-200x.1995.tb03389.x.
5
[Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].超重和肥胖儿童及青少年中的非酒精性脂肪性肝病
Med Clin (Barc). 2015 Jan 20;144(2):55-8. doi: 10.1016/j.medcli.2014.02.018. Epub 2014 Apr 24.
6
Serum glutamic-oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) levels in children and adolescents with intellectual disabilities.儿童和青少年智力障碍患者的血清谷氨酸草酰乙酸转氨酶(GOT)和谷氨酸丙酮酸转氨酶(GPT)水平。
Res Dev Disabil. 2010 Jan-Feb;31(1):172-7. doi: 10.1016/j.ridd.2009.08.005. Epub 2009 Oct 13.
7
The mechanism of release of hepatic enzymes in various liver diseases. II. Altered activity ratios of GOT to GPT in serum and liver of patients with liver diseases.各种肝脏疾病中肝酶释放的机制。II. 肝病患者血清和肝脏中谷草转氨酶与谷丙转氨酶活性比值的改变。
Acta Med Okayama. 1979 Oct;33(5):343-58.
8
Hepatic transaminase activity in alocholic liver disease.酒精性肝病中的肝转氨酶活性
Gastroenterology. 1980 Jun;78(6):1389-92.
9
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study.维生素E治疗小儿肥胖相关性肝病:一项随机研究。
J Pediatr Gastroenterol Nutr. 2004 Jan;38(1):48-55. doi: 10.1097/00005176-200401000-00012.
10
Alcohol, liver function tests, and high density lipoprotein cholesterol in university students.大学生中的酒精、肝功能测试与高密度脂蛋白胆固醇
Tohoku J Exp Med. 1980 Oct;132(2):241-2. doi: 10.1620/tjem.132.241.

引用本文的文献

1
Diet, exercise, and supplements: what is their role in the management of the metabolic dysfunction-associated steatotic liver disease in children?饮食、运动和补充剂:在儿童代谢功能障碍相关脂肪性肝病的管理中,它们各自扮演什么角色?
Endocrine. 2024 Sep;85(3):988-1006. doi: 10.1007/s12020-024-03783-7. Epub 2024 Mar 22.
2
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).NASPGHAN儿童非酒精性脂肪性肝病诊断与治疗临床实践指南:非酒精性脂肪性肝病专家委员会(ECON)及北美儿科胃肠病学、肝病学和营养学会(NASPGHAN)的建议
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334. doi: 10.1097/MPG.0000000000001482.
3
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: prevalence and correlates.非酒精性脂肪性肝病中的非器官特异性自身抗体:患病率及其相关因素
Dig Dis Sci. 2003 Nov;48(11):2173-81. doi: 10.1023/b:ddas.0000004522.36120.08.
4
Pediatric obesity.小儿肥胖症
Rev Endocr Metab Disord. 2001 Oct;2(4):371-83. doi: 10.1023/a:1011800532068.